Vir Biotechnology reported cash from operations of $123.33M and free cash flow of $123.29M for the quarter ended Jun 2026, up 202.6% year over year. This cash flow statement covers 32 quarters of results from Sep 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||||
| Net Income | 110.43M | 525.25M | 518.62M | -76.49M | 175.31M | -101.60M | -140.96M | -194.78M | -163.41M | -115.97M | -65.28M | -138.38M | -213.72M | -104.59M | -120.97M | -110.96M | -163.14M | -42.92M | -125.69M | 80.08M | ||||||||||||
| Share-based Compensation | 22.94M | 24.37M | 25.30M | 27.10M | 24.81M | 24.86M | 25.48M | 30.62M | 26.94M | 28.27M | 23.76M | 22.16M | 16.70M | 15.84M | 14.06M | 12.45M | 11.36M | 11.21M | 12.09M | 12.39M | ||||||||||||
| Deferred Taxes | -1.06M | 0.06M | -2.64M | |||||||||||||||||||||||||||||
| Gains from Equity Investments | -164.07M | 26.02M | 95.04M | 11.39M | 13.59M | -8.88M | 13.10M | 5.09M | 2.71M | 0.99M | 5.92M | -0.43M | -1.13M | 1.17M | -6.38M | 3.38M | -1.33M | 2.61M | 0.17M | 1.72M | ||||||||||||
| Gains from Investment Securities | ||||||||||||||||||||||||||||||||
| Asset Writedowns and Impairment | 2.76M | 11.04M | ||||||||||||||||||||||||||||||
| Cash from Operations | -105.81M | 7.70M | 550.09M | 960.14M | 117.90M | 35.13M | -125.78M | -389.25M | -155.83M | -107.93M | -109.39M | -77.85M | -171.48M | -87.64M | -78.12M | -120.22M | -167.57M | -25.88M | -132.39M | 123.33M | ||||||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||||||
| Amortizatization of Intangibles | 0.62M | -0.61M | -1.07M | -0.66M | 3.05M | 7.63M | 9.37M | 3.00M | -2.31M | -1.35M | -0.24M | -2.64M | -0.35M | -2.17M | -4.09M | -2.52M | -1.31M | -1.55M | -0.39M | -0.32M | ||||||||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 1.40M | 1.40M | 1.42M | 1.50M | 1.60M | 2.35M | 5.64M | 4.60M | 4.50M | 4.48M | 4.52M | 4.26M | 2.90M | 2.89M | 2.87M | 2.92M | 3.00M | 2.90M | 2.81M | 2.80M | ||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||||||
| Change in Receivables | 93.00M | 680.08M | 450.08M | -883.77M | -58.18M | -278.17M | -2.09M | -0.95M | 3.61M | 0.40M | -2.69M | 0.05M | 8.75M | |||||||||||||||||||
| Change in Account Payables | -5.89M | 0.79M | 3.83M | -1.39M | -4.45M | 2.80M | 6.56M | -0.93M | -7.53M | 2.63M | 0.73M | -2.89M | 3.11M | -1.94M | -1.42M | 8.86M | -5.40M | 2.96M | -4.23M | 12.31M | ||||||||||||
| Change in Accured Expenses | 8.80M | 71.99M | 433.56M | -288.18M | -80.24M | -80.66M | -4.04M | -265.73M | -47.15M | -41.92M | -30.00M | -4.79M | 19.27M | -48.49M | 18.01M | -26.01M | -11.62M | 10.10M | -17.22M | 8.39M | ||||||||||||
| Other Working Capital Changes | -0.89M | 2.48M | 17.58M | -2.02M | -40.06M | 63.86M | -9.49M | -17.80M | -26.90M | 17.91M | -50.16M | 0.48M | -1.50M | 28.16M | -5.06M | -0.88M | -4.21M | 2.78M | -2.27M | -3.79M | ||||||||||||
| Investing Activities | ||||||||||||||||||||||||||||||||
| Capital Expenditures | 6.01M | 13.07M | 15.84M | 20.60M | 18.99M | 12.57M | 6.87M | 9.46M | 3.71M | 1.53M | 1.87M | 0.67M | 2.77M | 2.00M | 1.63M | 2.54M | 0.32M | 0.35M | 0.39M | 0.03M | ||||||||||||
| Sales of Property, Plant and Equipment | 0.01M | -0.00M | 0.01M | -0.02M | 0.53M | 0.38M | 0.01M | 2.46M | 0.28M | 0.04M | 0.04M | -0.11M | ||||||||||||||||||||
| Change in Acquisitions & Divestments | 79.86M | 84.84M | 266.67M | 489.46M | 549.55M | 447.67M | 715.71M | 592.70M | 483.29M | 361.51M | 301.14M | 301.86M | 251.32M | 305.17M | 342.93M | 170.60M | 154.99M | |||||||||||||||
| Cash from Investing Activities | 73.86M | -377.58M | -105.39M | -272.33M | -662.61M | -153.13M | 98.08M | 230.31M | -58.95M | -104.81M | 28.42M | 211.61M | 118.60M | 140.74M | 126.82M | 56.46M | 40.45M | 86.65M | 11.84M | -197.14M | ||||||||||||
| Financing Activities | ||||||||||||||||||||||||||||||||
| Other financing activities | 3.69M | 3.44M | 0.48M | 1.58M | 1.54M | 0.93M | 2.31M | 0.74M | 0.34M | 0.89M | 0.22M | 2.38M | 1.16M | 0.60M | 1.16M | 1.04M | 0.17M | 1.44M | ||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||||||
| Net Shares Issued and Repurchased | 3.29M | 1.50M | 2.05M | |||||||||||||||||||||||||||||
| Net Equity Issued and Repurchased | -85.21M | 162.35M | -0.14M | |||||||||||||||||||||||||||||
| Misc. | ||||||||||||||||||||||||||||||||
| Cash from Financing Activities | 3.63M | 5.67M | 27.68M | 3.08M | 1.99M | 2.01M | 2.34M | 3.18M | 0.28M | 1.68M | 0.15M | 2.94M | 0.03M | 1.26M | 0.60M | 2.05M | 0.10M | 1.04M | 162.52M | 78.38M | ||||||||||||
| Change in Cash | -28.32M | -364.22M | 472.38M | 690.89M | -542.72M | -116.00M | -25.36M | -155.75M | -214.51M | -211.06M | -80.82M | 136.70M | -52.85M | 54.37M | 49.30M | -61.72M | -127.02M | 61.81M | 41.97M | 4.56M | ||||||||||||
| Free Cash Flow | -111.82M | -5.37M | 534.25M | 939.54M | 98.91M | 22.55M | -132.65M | -398.70M | -159.54M | -109.46M | -111.26M | -78.51M | -174.25M | -89.63M | -79.75M | -122.76M | -167.89M | -26.22M | -132.78M | 123.29M | ||||||||||||
| Net Cash Flow | -28.32M | -364.22M | 472.38M | 690.89M | -542.72M | -116.00M | -25.36M | -155.75M | -214.51M | -211.06M | -80.82M | 136.70M | -52.85M | 54.37M | 49.30M | -61.72M | -127.02M | 61.81M | 41.97M | 4.56M |